Ismaïl Elalamy, MD, PhD, is a Professor of Haematology and Head of the Haematology Department at Tenon University Hospital, Médecine Sorbonne Université Paris, and current President of the French Society of Angiology. He has been involved in the field of thrombosis and antithrombotic therapies since 1991, and his research interests include improving therapeutic strategies, identifying new biomarkers, and the application of novel diagnostic techniques to the clinic. He was a postdoc fellow at the Pasteur Institute, Paris, from 1998 to 2003, Associate Professor of Haematology at the APHP, Paris, from 1998 to 2008, and has also been Head of the Research Group on Hemostasis and Thrombosis in Cancer since 2005 which is now associated with INSERM UMR S-938 (Biology and Therapeutics in Cancer). In his current position, he has established an expert centre for HIT diagnosis and platelet disease management in Paris and a research center for cancer and thrombosis.